Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Coping strategies therapy significantly improves dementia carers' mental health, quality of life

  • Behavioral flexibility impaired after exposure to oxycodone

  • New insights link Fragile X Syndrome, Autism Spectrum Disorders

  • Rapid response for inflammation control in songbirds' brains could lead to therapies in humans

  • Epidemic spreading and neurodegenerative progression

  • Tapeworm found living inside a patient's brain: Worm removed and sequenced

  • Mental disorders due to permanent stress?

  • Brain injuries in mice treated using bone marrow stem cells, antioxidants

  • Repetitive transcranial magnetic stimulation studied for stroke rehab

  • Study of Lou Gehrig's disease shifts 'origin' focus to brain's motor neurons

  •